Abstract
Objective
To investigate the effect of Tripterygium polyglycosid on establishing airway eosinophil infiltration and related airway hyperresponsiveness of asthmatic mice.
Methods
A mature murine asthmatic model was made with ovabulmin sensitized and challenged C57BL/6 mice. Forty mice were divided into four groups with 10 mice in each group: mice sensitized and challenged with saline (WS group), mice sensitized and challenged with ovalbumin (WO group), mice sensitized and challenged with ovalbumin and treated with Tripterygium polyglycosid (TP group) and Dexamethasone (DXM group). The mice were intraperitoneally injected with 20 μg chicken ovabulmin emulsified in injected alum on days 0 and 14, then were challenged with an aerosol generated from 1% ovabulmin on days 24, 25 and 26. Tripterygium polyglycosid was injected intraperitoneally at 50 mg/kg on days 25, 26 and 27 after ovabulmin challenge. Dexamethasone was administrated to mice at 2 mg/kg on day 21, 23 before ovabulmin challenge. The airway hyperresponsiveness, mucus production, eosinophils in parabronchial area and bronchoalveolar lavage fluid and the level of interleukin-5, granulo-macrophage clone stimulating factor in bronchoalveolar lavage fluid were measured as indexes of inflammation.
Results
Tripterygium polyglycosid treatment after ovabulmin challenge completely inhibited eosinophil infiltration in bronchoalveolar lavage fluid [(0.63±0.34)×104 vs. (75.0±14.8)×104, P<0.05] and the peribrochial area (12.60±3.48 mm2 vs. 379.0±119.3 mm2, P<0.05), mucus overproduction in airway (2.8±1.7 vs. 7.1±5.6, P<0.05), and increased interleukin-5 levels in bronchoalveolar lavage fluid (28.8±2.8 pg/mL vs. 7.5±3.5 pg/mL, P<0.05). Meanwhile, Tripterygium polyglycosid treatment after ovabulmin challenge also partially inhibited airway hyperresponsiveness. The level of granulo-macrophage clone stimulating factor in bronchoalveolar lavage fluid didn’t change with drugs intervention.
Conclusions
The administration of Tripterygium polyglycosid could inhibit the established airway inflammation and reduce the airway hyperresponsiveness of allergic asthmatic mice. It provides a possible alternative therapeutic for asthma.
Similar content being viewed by others
References
Yang F, Dong XG, An ZM, Wu GQ, Zhang LJ, Gong NB, et al. Retrospect and prospect of studies on Tripterygium wilfordii Hook f. Chin J Integr Med 2005;11:89–96.
Tao X, Younger J, Fan FZ, Wang B, Lipsky PE. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthrit Rheum 2002;46:1735–1743.
Wan Y, Sun W, Zhang H, Yan Q, Chen P, Dou C, et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates prolonged mesangial lesions in experimental progressive glomerulonephritis. Nephron Exp Nephrol 2010;114:e7–e14.
Krakauer T, Chen X, Howard OM, Young HA. Triptolide attenuates endotoxin- and staphylococcal exotoxininduced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol Immunotoxicol 2005;27:53–66.
Law SK, Simmons MP, Techen N, Khan IA, He MF, Shaw PC, et al. Molecular analyses of the Chinese herb Leigongteng (Tripterygium wilfordii Hook.f.). Phytochemistry 2011;72:21–26.
Mao YP, Tao XL, Lipsky PE. Analysis of the stability and degradation products of triptolide. J Pharm Pharmacol 2000;52(1):3–12.
Busse WW, Lemanske RF J. Asthma. N Engl J Med 2001;344:350–362.
Wang XH, Zhang ZY. Effect of Tripterygium polyglucoside on T-lymphocyte subsets and serum interleukin-5 level in asthma patients. Chin J Integr Tradit West Med (Chin) 2001;21:25–27.
Ochkur SI, Jacobsen EA, Protheroe CA, Biechele TL, Pero RS, McGarry MP, et al. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol 2007;178:7879–7889.
Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766–775.
Wang HY, Shen HH, Lee JJ, Lee NA. CD69 expression on airway eosinophils and airway inflammation in a murine model of asthma. Chin Med J 2006;119:1983–1990.
Li Y, Yu C, Zhu WM, Xie Y, Qi X, Li N, et al. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Mol Immunol 2010;47:2467–2474.
Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218–230.
Asquith KL, Ramshaw HS, Hansbro PM, Beagley KW, Lopez AF, Foster PS. The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol 2008;180:1199–2006.
Pazdrak K, Young TW, Stafford S, Olszewska-Pazdrak B, Straub C, Starosta V, et al. Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation. J Immunol 2008;180:4182–4190.
Jiang M, Dong YZ, Zhang FC, Yan CL, Zhu PL, Li B, et al. The immunomodelatory effect of Tripterygium polyglycoside on T cells. Chin Med J (Chin) 1992;72:473–475.
Lai JH, Ho LJ, Lu KC, Chang DM, Shao MF, Han SH. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspases and is independent of Fas/Fas ligand interaction. J Immunol 2001;166:6914–6924.
Premkumar V, Dey M, Dorn R, Raskin I. MyD88-dependent and independent pathways of Toll-like receptors are engaged in biological activity of Triptolide in ligandstimulated macrophages. BMC Chem Biol 2010;10:3.
Leonie S van Rijt, Prins JB, Pieter JML, Kris T, Victor C de Vries, Henk CH, et al. Allergen-induced accumulation of airway dendritic cells is supported by an increase in CD31hiLy-6Cneg bone marrow precursors in a mouse model of asthma. Immunobiology 2002;100:3663–3671.
Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 2004;173:6409–6417.
Sugita M, Kuribayashi K, Nakagomi T, Miyata S, Matsuyama T, Kitada O. Allergic bronchial asthma: airway inflammation and hyperresponsiveness. Intern Med 2003;42:636–643.
Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004;169:860–867.
Walsh GM, Sexton DW, Blaylock MG. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J Endocrinol 2003;178:37–43.
Ian PL, Julia DR, Kent TH. Prevention of Allergen-Specific, Th2-Biased Immune Responses in vivo: role of increased IL-12 and IL-18 responsiveness. J Immunol 2005;175:4956–4962.
Xu JY, Jiang FX, Qiu YJ. Effects of Tripterygium polyglucoside (TP) on cytokines and eosinophil apoptosis in asthmatic patients in sputum. Chin J Microbiol Immunol 2004;34:134–136.
Xiao C, Zhao L, Liu Z, Lu C, Zhao N, Yang D, et al. The effect of triptolide on CD4+ and CD8+ cells in the Peyer’s patch of DA rats with collagen induced arthritis. Nat Prod Res 2009;23:1699–1706.
Justice JP, Crosby J, Borchers MT, Tomkinson A, Lee JJ, Lee NA. CD4+ T cell-dependent airway mucus production occurs in response to IL-5 expression in the lung. Am J Physiol 2002;282:L1066–1076.
Meurs H, Gosens R, Zaagsma J. Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models. Eur Respir J 2008;32:487–502.
Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 2002;8:2666–2674.
Wang Y, Jia L, Wu CY. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis. Mol Immunol 2007;44:2686–2696.
Wu F, Han M, Wilson JX. Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation. J Mol Med 2008;22:489–496.
Hamelmann E, Gelfand EW. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness. Int Arch Allergy Immunol 1999;120:8–16.
Nakae S, Lunderius C, Ho LH, Schäfer B, Tsai M, Galli SJ. TNF can contribute to multiple features of ovalbumininduced allergic inflammation of the airways in mice. J Allergy Clin Immunol 2007;119:680–686.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China (No. 30600266)
Rights and permissions
About this article
Cite this article
Chen, Cg., Wang, Hy., Dai, Y. et al. Tripterygium polyglycosid attenuates the established airway inflammation in asthmatic mice. Chin. J. Integr. Med. 19, 282–288 (2013). https://doi.org/10.1007/s11655-013-1410-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-013-1410-1